Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin Bremer

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Clinical and Translational Medicine|July 31, 2022
CD47-SIRPα blocking-based immunotherapy: Current and prospective therapeutic strategiesRenée Bouwstra, Tom van Meerten, Edwin Bremer
Molecular & Cellular Oncology|May 28, 2019
Does cancer cell-expressed SLAMF7 impact on CD47-mediated phagocytosis?Renee Bouwstra, Tom van Meerten, Edwin Bremer
Cancer Letters|January 11, 2011
Antibody-based fusion proteins to target death receptors in cancerMarco de Bruyn, Edwin Bremer, Wijnand Helfrich
Cancer Communications (London, England)|July 21, 2021
Harnessing the soil: reshaping the tumor microenvironment towards an antitumor immune state by low-dose metforminYusheng Lin, Shuhong Wang, Edwin Bremer, et al.
Expert Opinion on Therapeutic Targets|March 10, 2016
Calreticulin, a therapeutic target?Paul Eggleton, Edwin Bremer, Elzbieta Dudek, et al.
Cancers|April 30, 2021
The Role of Macrophages in Cancer Development and TherapyEwa Cendrowicz, Zuzanna Sas, Edwin Bremer, et al.
Cancers|January 21, 2022
The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional ActivityYuan He, Martijn Vlaming, Tom van Meerten, et al.
International Journal of Molecular Sciences|October 27, 2020
The Neutrophil: The Underdog That Packs a Punch in the Fight against CancerNatasha Ustyanovska Avtenyuk, Nienke Visser, Edwin Bremer, et al.
Medicinal Research Reviews|July 28, 2011
Therapeutic potential of Galectin-9 in human diseaseValerie R Wiersma, Marco de Bruyn, Wijnand Helfrich, et al.
Medicinal Research Reviews|October 11, 2018
The multifaceted role of autophagy in cancer and the microenvironmentHendrik Folkerts, Susan Hilgendorf, Edo Vellenga, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Clinical and Translational Medicine|July 31, 2022
CD47-SIRPα blocking-based immunotherapy: Current and prospective therapeutic strategiesRenée Bouwstra, Tom van Meerten, Edwin Bremer
Molecular & Cellular Oncology|May 28, 2019
Does cancer cell-expressed SLAMF7 impact on CD47-mediated phagocytosis?Renee Bouwstra, Tom van Meerten, Edwin Bremer
Cancer Letters|January 11, 2011
Antibody-based fusion proteins to target death receptors in cancerMarco de Bruyn, Edwin Bremer, Wijnand Helfrich
Cancer Communications (London, England)|July 21, 2021
Harnessing the soil: reshaping the tumor microenvironment towards an antitumor immune state by low-dose metforminYusheng Lin, Shuhong Wang, Edwin Bremer, et al.
Expert Opinion on Therapeutic Targets|March 10, 2016
Calreticulin, a therapeutic target?Paul Eggleton, Edwin Bremer, Elzbieta Dudek, et al.
Cancers|April 30, 2021
The Role of Macrophages in Cancer Development and TherapyEwa Cendrowicz, Zuzanna Sas, Edwin Bremer, et al.
Cancers|January 21, 2022
The Implementation of TNFRSF Co-Stimulatory Domains in CAR-T Cells for Optimal Functional ActivityYuan He, Martijn Vlaming, Tom van Meerten, et al.
International Journal of Molecular Sciences|October 27, 2020
The Neutrophil: The Underdog That Packs a Punch in the Fight against CancerNatasha Ustyanovska Avtenyuk, Nienke Visser, Edwin Bremer, et al.
Medicinal Research Reviews|July 28, 2011
Therapeutic potential of Galectin-9 in human diseaseValerie R Wiersma, Marco de Bruyn, Wijnand Helfrich, et al.
Medicinal Research Reviews|October 11, 2018
The multifaceted role of autophagy in cancer and the microenvironmentHendrik Folkerts, Susan Hilgendorf, Edo Vellenga, et al.
Pageof 10